We're really excited to announce the results from the Opt2mise trial have been published, and were presented at the American Diabetes Association Scientific Sessions a few weeks ago. This is the largest global study to evaluate and compare insulin pump therapy versus multiple daily insulin injections in people with type 2 diabetes.